3
Announcements
Trials
Browse
Landscape
Status
Recruiting
1
Sponsor Class
INDUSTRY
1
Study Type
Observational
1
Sponsor
Cancer Type
Thoracic
1
Sarcoma
1
Head & Neck
1
Gynecologic
1
Genitourinary
1
Gastrointestinal
1
Dermatologic
1
Conditions
Breast Neoplasms
57
Neoplasm Metastasis
21
Carcinoma, Non-Small-Cell Lung
9
Stomach Neoplasms
8
Brain Neoplasms
8
Colorectal Neoplasms
7
Triple Negative Breast Neoplasms
4
Pancreatic Neoplasms
4
Ovarian Neoplasms
4
Endometrial Neoplasms
4
Salivary Gland Neoplasms
3
Recurrence
3
Neoplasms
3
Esophageal Neoplasms
3
Adenocarcinoma
3
Prostatic Neoplasms
2
Meningeal Carcinomatosis
2
HER2-positive Gastric Cancer
2
Colonic Neoplasms
2
Breast Cancer With Brain Metastasis
2
Advanced Solid Tumor
2
Advanced Breast Cancer
2
Adenocarcinoma Of Esophagus
2
Vulvar Neoplasms
1
Vaginal Neoplasms
1
Uterine Neoplasms
1
Uterine Cervical Neoplasms
1
Urinary Bladder Neoplasms
1
Urethral Neoplasms
1
Unresectable Locally Recurrent Breast Cancer
1
Interventions
aldesleukin
2
Radiotherapy
2
Radiation
2
Magnetic Resonance Spectroscopy
2
Brachytherapy
2
Adoptive Transfer
2
zimberelimab
1
trastuzumab deruxtecan
1
talazoparib
1
liposomal doxorubicin
1
entinostat
1
dostarlimab
1
bintrafusp alfa protein, human
1
belzutifan
1
Therapeutic Touch
1
Surveys and Questionnaires
1
Specimen Handling
1
Sonazoid
1
Radiotherapy, Intensity-Modulated
1
Platinum
1
Paclitaxel
1
Observation
1
Nivolumab
1
Methods
1
Interviews as Topic
1
Gemcitabine
1
Fluorodeoxyglucose F18
1
FAPI-46
1
Educational Status
1
Early Intervention, Educational
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Vaginal Neoplasms
×
trastuzumab deruxtecan
×
1 year
×
Clear all
NCT07124000
2026-06-01
DP-04
AstraZeneca
Recruiting
100 enrolled